CORD-19:c6b75757f2a356c2bbc3ec1d986d17a3d0048701 / 6710-7035 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T48","span":{"begin":0,"end":325},"obj":"Sentence"},{"id":"TextSentencer_T48","span":{"begin":0,"end":325},"obj":"Sentence"},{"id":"TextSentencer_T48","span":{"begin":0,"end":325},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"For F. necrophorum, a selective anaerobic plate (fastidious anaerobe agar (Lab M) with 5% horse blood (SVA) supplemented with vancomycin 2.5 mg/L (ICN Biomedicals, Irvine, CA, USA) and nalidixic acid 5.0 mg/L (MP Biomedicals, Santa Ana, CA, USA)), and with a kanamycin tablet 500 μg (Rosco, Taastrup, Denmark) was used [21] ."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T48","span":{"begin":0,"end":325},"obj":"Sentence"}],"text":"For F. necrophorum, a selective anaerobic plate (fastidious anaerobe agar (Lab M) with 5% horse blood (SVA) supplemented with vancomycin 2.5 mg/L (ICN Biomedicals, Irvine, CA, USA) and nalidixic acid 5.0 mg/L (MP Biomedicals, Santa Ana, CA, USA)), and with a kanamycin tablet 500 μg (Rosco, Taastrup, Denmark) was used [21] ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T39","span":{"begin":103,"end":106},"obj":"Disease"},{"id":"T40","span":{"begin":310,"end":313},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0015197"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"For F. necrophorum, a selective anaerobic plate (fastidious anaerobe agar (Lab M) with 5% horse blood (SVA) supplemented with vancomycin 2.5 mg/L (ICN Biomedicals, Irvine, CA, USA) and nalidixic acid 5.0 mg/L (MP Biomedicals, Santa Ana, CA, USA)), and with a kanamycin tablet 500 μg (Rosco, Taastrup, Denmark) was used [21] ."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T18","span":{"begin":96,"end":101},"obj":"Body_part"}],"attributes":[{"id":"A18","pred":"uberon_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"For F. necrophorum, a selective anaerobic plate (fastidious anaerobe agar (Lab M) with 5% horse blood (SVA) supplemented with vancomycin 2.5 mg/L (ICN Biomedicals, Irvine, CA, USA) and nalidixic acid 5.0 mg/L (MP Biomedicals, Santa Ana, CA, USA)), and with a kanamycin tablet 500 μg (Rosco, Taastrup, Denmark) was used [21] ."}